ArticleScientific reports2024

CRISPR/Cas9 targeting of passenger single nucleotide variants in haploinsufficient or essential genes expands cancer therapy prospects.

Hakhyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.